Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texts and trackers aim to get diabetics out of their chairs

NCT ID NCT04219800

Disease control Sponsor: Umeå University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using activity trackers, text reminders, and short exercise videos could help people with type 2 diabetes reduce the time they spend sitting at work. Forty-six adults with type 2 diabetes who had mostly desk jobs took part. The goal was to see if these mobile health tools could lead to less sitting, more steps, and better overall health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
activity tracker armband, SMS reminders, and mobile video instructions
What this could lead to
If successful, this approach could offer a low-cost way to help people with type 2 diabetes reduce sitting time and improve health outcomes.
What could go wrong
This is a small, completed trial with only 46 participants, so results may not apply to everyone. The intervention focuses on behavior change, which can be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Dec 2020

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 64 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Type 2 Diabetes Melltitus * 40-64 years * HbA1c 48-100 mmol/mol * BMI ≥ 25 kg/m2 * Working at least 75% of full-time in a mainly seated job. Exclusion Criteria: * Pregnancy * Regular vigorous intensity exercise * Severe disease or for other reason unable to follow the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus type 2

Contacts and locations

Locations

  • Björkskatans Hälsocentral

    Luleå, Norrbotten County, Sweden

  • Clinical Research Centre

    Östersund, Sweden

  • Clinical Research Centre

    Umeå, Sweden

  • Hallsbergs hälsocentral

    Hallsberg, Sweden

  • Kärna Vårdcentral

    Linköping, Sweden

  • Torsviks Vårdcentral

    Stockholm, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.